Interim results
Summary by AI BETAClose X
Insig AI plc / EPIC: INSG / Market: AIM
9 December 2025
INSIG AI PLC
("INSG" or the "Company")
Unaudited Interim Results for the Six Months ended 30 September 2025
Insig AI plc (AIM:INSG), a leading provider of AI-led analytics and machine learning solutions company, is pleased to announce its unaudited interim results for the six months ended 30 September 2025 ("H1-25") and to provide an update on the Company's progress post the half year end.
Highlights
· Operating loss of £1.1 million in H1-25 (H1-24: £5.2 million, including impairments)
· H1 revenue growth of 164% to £438k
· Two new vertical markets entered, with two new customer wins post period end
· Cash at period end of £0.03 million (H1-24 £0.23 million)
· £1 million new equity raised at 30.5p per share post period end
· Plans to deploy capital into the digital assets and AI space
Richard Bernstein, CEO commented: "We delivered a successful first half with strong revenue growth and several new client wins. Since the period end, we have secured further new client wins reinforcing the momentum in our core commercial activities. In recent months, much of our focus has been on evaluating opportunities and structures within the digital assets and AI space. In 2026, we plan to start to deploy capital in these areas. We believe this can also generate very substantial returns for our shareholders. I am excited about our prospects for 2026 and beyond."
For further information, please visit www.insig.ai or contact:
|
Insig AI plc |
|
|
Richard Bernstein |
|
|
|
|
|
|
|
|
Zeus (Nominated Adviser & Broker) |
+44 (0)20 3829 5000 |
|
David Foreman / James Hornigold |
|
|
CMC Markets (Joint Broker) |
+44 (0) 203 003 8632 |
|
Doug Crippin |
|
Chief Executive's Report
Dear Shareholders,
I am pleased to report on a busy and successful first half. We have signed several new clients, deepened our engagement with existing customers and achieved revenue growth of 164% from H-24.
In April 2025, we were delighted that the Financial Conduct Authority ("FCA") became a client. This subscription service licence agreement provides the FCA with access to Insig AI's Transparency and Disclosure Index ("TDI") covering UK listed companies. The FCA accesses our toolkit that allows users to search, filter, analyse and benchmark company disclosures, which are evidence based and fully traceable to original company reports. This engagement represents a significant regulatory validation of our proprietary data architecture and analytical capabilities.
In April 2025, we also announced a new client win from a London-based, European focused asset manager with assets under management of more than £1 billion. The work won related to the automation of data collection and ingestion and comprises both a licence fee and an ongoing annual retainer, establishing a recurring revenue relationship.
In May 2025, we announced further client wins including a London-based asset manager with assets under management of more than £1 billion specialising in European credit investments utilising Insig AI's data infrastructure framework. Later that month, we also secured a new client win from a London-based asset manager with assets under management of more than £25 billion. The client specialises in global macroeconomic events and has entered into a commercial agreement that included both a licence fee and an annual retainer. This win also marked the first commercial deployment of Insig AI's Generative Intelligence Engine - a proprietary product that enables organisations to apply their own expert decision-making methodology at scale to their proprietary data in a secure and auditable environment. We have already secured additional work from this client and are currently mapping out further deployments across its business.
Pleasingly, all client wins in H1 have either already resulted in additional business or involve current discussions that may result in additional revenues.
Financial headlines
In summary, the operating loss we are reporting of £1.1 million compares with an operating loss of £5.2 million. Last year's operating loss was adversely impacted by impairments of £4.4 million, prior to which the operating loss was £0.8 million. Net cash used in operations reduced to £0.65 million from £0.97 million in the corresponding period. Revenues increased by 164% to £0.44 million from £0.17 million in the corresponding period. Cash and cash equivalents at the period end were £0.03 million, as against cash and cash equivalents for the corresponding period of £0.23 million.
Equity funding
In June 2025, I entered into an equity funding facility with the Company During the period, the Company issued 1,750,000 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") at 20 pence per Ordinary Share. The subscription price of 20 pence represented a premium of 23% to the closing share price of 16.25 pence on 21 March 2025, when the Equity Funding Facility was proposed.
After the period end, the Company raised £1 million gross from the issuance of 3,279,569 Ordinary shares at 30.5p a share.
Deploying our assets to maximise shareholder returns
Put simply, an asset represents a probable future economic benefit. Our assets include our technology, our clients and our people. It is important that now we fully deploy the experience, skills and networks of the team that we have assembled.
In September, I reported that the Company was considering various strategic options, in part to more fully utilise the expertise of Peter Pereira Gray, the former Chief Executive of The Wellcome Trust's Investment Division, who joined Insig AI as a Strategic and Asset Allocation Adviser in July 2025. I stated that this could enable us to invest new capital in digital assets and related enterprises, in areas which the Board and I believe to be a natural evolution for Insig AI.
In October, we announced the appointment of Lawrence Lundy-Bryan as Digital Assets Adviser. Lawrence has over a decade of digital assets experience. In 2015, Lawrence worked with Intel on its distributed ledger technology strategy. Lawrence has contributed to policy through the UK Cryptoasset Taskforce led by HM Treasury, the FCA, and the Bank of England.
As founder of and Investment Adviser to Crystal Amber Fund, I have a long track record of delivering for investors. Last month, Crystal Amber Fund reported investment returns over the last three and five years of 112% and 270% respectively. Crystal Amber also announced my intention to resign to pursue other ventures.
I believe that Peter, Lawrence and I are well placed to utilise the combination of our experience, investment focus and disciplines alongside the valuable technology that Insig AI's data insights provide.
In recent months, we have evaluated investment opportunities and structures to apply value investment discipline to digital assets as well as AI businesses where our data insights can be directly applied. Our conclusion is that a $2.5 trillion asset class requires institutional access and that Insig AI is ideally positioned to provide such access. It is the area of providing solutions to the needs of businesses in this new and exciting digital/AI economy that excites us and which we intend to be our focus. For example, payment systems are going to be revolutionised. We think polling is likely to see a similar transformation. We have zero interest in so called memes or constructing a portfolio of so-called "products" such as TRUMP or DOGECOIN. Our focus will predominantly be on the "picks and shovels" and where we see evidence based fundamental mispricing of digital assets that we can capitalise upon for the benefit of our shareholders.
Prospects
In September 2025, when we published our preliminary results for the year to March 2025, I commented that with new reporting requirements come into force, corporates will need to collate data in a way that is well suited to our solutions, as manual data collection and analysis would become relatively costly, cumbersome and ultimately obsolete. We were therefore delighted in the following month, to announce a new contract with an international law firm. Our automated solution collects, processes, and compares corporate reporting documents using AI customised workflows. This represented a further deployment of Insig AI's Generative Intelligence Engine and the first time that Insig AI has sold its technology to a legal practice. Last month, we secured a further client win automating the benchmarking of corporate reporting disclosures against international standards. This new client is a global advisory firm operating in more than 70 countries. These wins represent two new vertical markets for the Company and importantly, demonstrates the versatility of our platform across regulated industries. We have several new proposals now before prospects, many of which, we expect to convert into material revenues.
As highlighted above, in recent months, much of our focus has been on evaluating the digital assets and AI space. We believe this can generate very substantial returns for our shareholders. To be clear, we see such investment as supplementing our existing activities, not replacing them. With our objective of continuing to grow revenues and accessing and deploying capital in a new $2.5 trillion asset class, I am excited about our prospects for 2026 and beyond.
Richard Bernstein
Chief Executive Officer
8 December 2025
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
|
|
Notes |
6 months to 30 September 2025 Unaudited
£ |
6 months to 30 September 2024 Unaudited (Restated) £ |
|
Continuing operations |
|
|
|
|
Revenue |
6 |
437,800 |
165,780 |
|
Cost of sales |
|
(88,972) |
(82,100) |
|
Gross profit |
|
348,828 |
83,680 |
|
Administration expenses |
|
(1,257,801) |
(914,823) |
|
Other gains/(losses) |
|
(164,768) |
(296) |
|
Impairments |
|
- |
(4,404,000) |
|
Operating loss |
|
(1,073,741) |
(5,235,439) |
|
Finance income |
|
241 |
299 |
|
Finance costs |
|
(66,672) |
(80,518) |
|
Loss before income tax |
|
(1,140,172) |
(5,315,658) |
|
Tax credit |
|
- |
1,101,000 |
|
Loss for the period after income tax |
|
(1,140,172) |
(4,214,658) |
|
Total comprehensive loss attributable to owners of the Parent |
|
(1,140,172) |
(4,214,658) |
|
Basic and diluted earnings per share |
5 |
(0.95)p |
(3.89)p |
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
|
|
Notes |
As at 30 September 2025 Unaudited
£ |
As at 31 March 2025 Audited
£ |
As at 30 September 2024 Unaudited (Restated) £ |
|
Non-Current Assets |
|
|
|
|
|
Property, plant and equipment |
|
2,492 |
3,670 |
3,640 |
|
Available for sale investments |
|
123,750 |
123,750 |
123,750 |
|
|
|
126,242 |
127,420 |
127,390 |
|
Current Assets |
|
|
|
|
|
Trade and other receivables |
|
151,659 |
92,570 |
67,654 |
|
Cash and cash equivalents |
|
28,094 |
328,796 |
226,376 |
|
|
|
179,753 |
421,366 |
294,030 |
|
Total Assets |
|
305,995 |
548,786 |
421,420 |
|
|
|
|
|
|
|
Non-Current Liabilities |
|
- |
- |
- |
|
Current Liabilities |
|
|
|
|
|
Trade and other payables |
|
500,394 |
322,313 |
173,227 |
|
Convertible loans |
7 |
1,799,213 |
1,732,541 |
1,723,262 |
|
|
|
2,299,607 |
2,054,854 |
1,896,489 |
|
Total Liabilities |
|
2,299,607 |
2,054,854 |
1,896,489 |
|
Net Assets |
|
(1,993,612) |
(1,506,068) |
(1,475,069) |
|
Capital and Reserves Attributable to Equity Holders of the Company |
|
|
|
|
|
Share capital |
|
3,269,874 |
3,252,374 |
3,230,499 |
|
Share premium |
|
42,739,675 |
42,243,659 |
41,915,534 |
|
Other reserves |
|
325,583 |
325,583 |
325,583 |
|
Share based payments reserve |
|
445,545 |
314,352 |
181,953 |
|
Retained losses |
|
(48,774,289) |
(47,642,036) |
(47,099,898) |
|
Equity attributable to shareholders of the parent |
|
(1,993,612) |
(1,506,068) |
(1,446,329) |
|
Non-controlling interests |
|
- |
- |
(28,740) |
|
Total Equity |
|
(1,993,612) |
(1,506,068) |
(1,475,069) |
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY
|
|
Note |
Share capital £ |
Share premium £ |
Share based payment reserve £ |
Other reserves £ |
Retained losses £ |
Total equity £ |
Non-Controlling Interest £ |
Total equity £ |
||||
|
Balance as at 1 April 2024 (restated) |
|
3,149,058 |
40,810,725 |
121,597 |
325,583 |
(42,916,216) |
1,490,747 |
(28,740) |
1,462,007 |
||||
|
Loss for the period (restated) |
|
- |
- |
- |
- |
(4,214,658) |
(4,214,658) |
- |
(4,214,658) |
||||
|
Total comprehensive loss for the period |
|
- |
- |
- |
- |
(4,214,658) |
(4,214,658) |
- |
(4,214,658) |
||||
|
Issue of shares |
|
81,441 |
1,104,809 |
- |
- |
- |
1,186,250 |
- |
1,186,250 |
||||
|
Share based payment (restated) |
|
- |
- |
91,332 |
- |
- |
91,332 |
- |
91,332 |
||||
|
Expired options (restated) |
|
- |
- |
(30,976) |
|
30,976 |
- |
- |
- |
||||
|
Total transactions with owners, recognised in equity |
|
81,441 |
1,104,809 |
60,356 |
- |
30,976 |
1,277,582 |
- |
1,277,582 |
||||
|
Balance as at 30 September 2024 (restated) |
|
3,230,499 |
41,915,534 |
181,953 |
325,583 |
(47,099,898) |
(1,446,329) |
(28,740) |
(1,475,069) |
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Balance as at 1 April 2025 |
|
3,252,374 |
42,243,659 |
314,352 |
325,583 |
(47,642,036) |
(1,506,068) |
- |
(1,506,068) |
||||
|
Loss for the period |
|
- |
- |
- |
- |
(1,140,172) |
(1,140,172) |
- |
(1,140,172) |
||||
|
Total comprehensive loss for the period |
|
- |
- |
- |
- |
(1,140,172) |
(1,140,172) |
- |
(1,140,172) |
||||
|
Issue of shares |
|
17,500 |
332,500 |
- |
- |
- |
350,000 |
- |
350,000 |
||||
|
Cost of capital |
|
- |
163,516 |
- |
- |
- |
163,516 |
|
163,516 |
||||
|
Share based payment |
|
- |
- |
139,112 |
- |
- |
139,112 |
- |
139,112 |
||||
|
Expired options |
|
- |
- |
(7,919) |
- |
7,919 |
- |
- |
- |
||||
|
Total transactions with owners, recognised in equity |
|
17,500 |
496,016 |
131,193 |
- |
7,919 |
652,628 |
- |
652,628 |
||||
|
Balance as at 30 September 2025 |
|
3,269,874 |
42,739,675 |
445,545 |
325,583 |
(48,774,289) |
(1,993,612) |
- |
(1,993,612) |
||||
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
|
|
|
Notes |
6 months to 30 September 2025 Unaudited
£ |
6 months to 30 September 2024 Unaudited (Restated) £ |
|
Cash flows from operating activities |
|
|
|
|
|
Loss before taxation |
|
|
(1,140,172) |
(5,315,658) |
|
Adjustments for: |
|
|
|
|
|
Depreciation and amortisation |
|
|
1,178 |
2,013 |
|
Impairments |
|
|
- |
4,404,000 |
|
Finance expense |
|
|
66,672 |
80,518 |
|
Share options expense |
|
|
139,112 |
91,332 |
|
Increase/(decrease) in trade and other receivables |
|
|
(72,880) |
37,085 |
|
Increase/(decrease) in trade and other payables |
|
|
355,388 |
(173,261) |
|
Net cash used in operations |
|
|
(650,702) |
(873,971) |
|
Cash flows from investing activities |
|
|
|
|
|
Net cash used in investing activities |
|
|
- |
- |
|
Cash flows from financing activities |
|
|
|
|
|
Proceeds from share allotments |
|
|
350,000 |
1,062,500 |
|
Net cash generated from financing activities |
|
|
350,000 |
1,062,500 |
|
Net decrease in cash and cash equivalents |
|
|
(300,702) |
188,529 |
|
Cash and cash equivalents at beginning of period |
|
|
328,796 |
37,847 |
|
Cash and cash equivalents at end of period |
|
|
28,094 |
226,376 |
NOTES TO THE INTERIM FINANCIAL STATEMENTS
1. General Information
Insig AI plc is a data science and machine learning company listed on the AIM Market of the London Stock Exchange.
The Company is domiciled in the United Kingdom and incorporated and registered in England and Wales, with registration number 03882621. The Company's registered office is 6 Heddon Street, London, W1B 4BT.
2. Basis of Preparation
The condensed consolidated interim financial statements have been prepared in accordance with the requirements of the AIM Rules for Companies. As permitted, the Company has chosen not to adopt IAS 34 "Interim Financial Statements" in preparing this interim financial information. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 March 2025, which have been prepared in accordance with UK adopted international accounting standards.
The interim financial information set out above does not constitute statutory accounts within the meaning of the Companies Act 2006. It has been prepared on a going concern basis in accordance with the recognition and measurement criteria of UK adopted international accounting standards.
Statutory financial statements for the year ended 31 March 2025 were approved by the Board of Directors on 18 September 2025 and delivered to the Registrar of Companies. The report of the auditors on those financial statements was unqualified with a material uncertainty in relation to the Company's ability to continue as a going concern. The condensed interim financial statements are unaudited and have not been reviewed by the Company's auditor.
Going concern
These financial statements have been prepared on the going concern basis. Given the Group's current cash position and its demonstrated ability to raise capital, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting preparing the condensed interim financial statements for the period ended 30 September 2025.
Notwithstanding the above, a material uncertainty exists that may cast significant doubt on the Group's ability to continue as a going concern and, therefore, that the Group may be unable to realise their assets or settle their liabilities in the ordinary course of business. As a result of their review, and despite the aforementioned material uncertainty, the Directors have confidence in the Groups forecasts and have a reasonable expectation that the Group will continue in operational existence for the going concern assessment period and have therefore used the going concern basis in preparing these consolidated financial statements.
The factors that were extant at 31 March 2025 are still relevant to this report and as such reference should be made to the going concern note and disclosures in the 2025 Annual Report and Financial Statements ("2025 Annual Report").
Risks and uncertainties
The Board continuously assesses and monitors the key risks of the business. The key risks that could affect the Company's medium term performance and the factors that mitigate those risks have not substantially changed from those set out in the Company's 2025 Annual Report and Financial Statements, a copy of which is available on the Company's website: www.insgai.com. The key financial risks are liquidity risk, credit risk, interest rate risk and fair value estimation.
Critical accounting estimates
The preparation of condensed interim financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the end of the reporting period. Significant items subject to such estimates are set out in Note 4 of the Company's 2025 Annual Report and Financial Statements. The nature and amounts of such estimates have not changed significantly during the interim period.
3. Accounting Policies
Except as described below, the same accounting policies, presentation and methods of computation have been followed in these condensed interim financial statements as were applied in the preparation of the Company's annual financial statements for the period ended 31 March 2025.
3.1 Changes in accounting policy and disclosures
The following amendments to standards have become effective for the first time for annual reporting periods commencing on 1 January 2024 and have been adopted in preparing these financial statements:
|
Standard |
|
Impact on initial application |
|
Effective date |
|
IAS 7 (Amendments) and IFRS 7 |
|
Supplier Finance Arrangements |
|
1 January 2024 |
|
IAS 1 (Amendments) |
|
Classification of Liabilities as Current or Non-Current |
|
1 January 2024 |
|
IFRS 16 (Amendments) |
|
Lease Liability in a Sale and Leaseback |
|
1 January 2024 |
|
IAS 1 (Amendments) |
|
Presentation of Financial Statements |
|
1 January 2024 |
|
IAS 1 (Amendments) |
|
Non-Current Liabilities with Covenants |
|
1 January 2024 |
|
IAS 21 (Amendments) |
|
Lack of Exchangeability |
|
1 January 2024 |
The adoption of these amendments had no material impact on the financial statements.
At the date of approval of these financial statements, the following amendments to IFRS which have not been applied in these financial statements were in issue, but not yet effective, until annual periods beginning on 1 January 2025, 2026 and 2027:
|
Standard |
|
Impact on initial application |
|
Effective date |
|
IAS 21 (Amendments) |
|
Lack of Exchangeability |
|
1 January 2025 |
|
IFRS 9 |
|
Classification and Measurement of Financial Instruments |
|
1 January 2026 |
|
IFRS 18 |
|
Presentation and Disclosure in Financial Statements |
|
1 January 2027 |
|
IFRS 19 |
|
Subsidiaries without Public Accountability: Disclosures |
|
1 January 2027 |
Subject to endorsement by the UK
4. Dividends
No dividend has been declared or paid by the Company during the six months ended 30 September 2025 (six months ended 30 September 2024: £nil).
5. Loss per Share
The calculation of earnings per share is based on a loss of £1,140,172 for the six months ended 30 September 2025 (six months ended 30 September 2024: £5,315,658) and the weighted average number of shares in issue in the period ended 30 September 2025 of 120,401,899 (six months ended 30 September 2024: 108,059,330).
No diluted earnings per share is presented for the six months ended 30 September 2025 or six months ended 30 September 2024 as the effect on the exercise of share options would be to decrease the loss per share.
6. Business segment analysis
6 months to 30 September 2025 Unaudited
|
|
Machine learning and Data services £ |
Total
£ |
|
Revenue |
437,800 |
437,800 |
|
Costs of sales |
(88,972) |
(88,972) |
|
Administrative expenses |
(1,257,801) |
(1,257,801) |
|
Other gains/(losses) |
(164,768) |
(164,768) |
|
Finance Income |
241 |
241 |
|
Finance costs |
(66,672) |
(66,672) |
|
Profit/(Loss) before tax per reportable segment |
(1,140,172) |
(1,140,172) |
6 months to 30 September 2024 Unaudited (restated)
|
|
Machine learning and Data services £ |
Total
£ |
|
Revenue |
165,780 |
165,780 |
|
Cost of sales |
(82,100) |
(82,100) |
|
Administrative expenses |
(914,823) |
(914,823) |
|
Other gains/(losses) |
(296) |
(296) |
|
Impairments |
(4,404,000) |
(4,404,000) |
|
Finance Income |
299 |
299 |
|
Finance costs |
(80,518) |
(80,518) |
|
Profit/(Loss) before tax per reportable segment |
(5,315,658) |
(5,315,658) |
7. Convertible loan notes
|
|
|
|
|
|
||
|
|
CLN 1 |
CLN 2 |
30 September 2025 |
|||
|
|
£ |
£ |
£ |
|||
|
|
|
|
|
|||
|
Convertible loan note - opening liability |
1,105,525 |
545,469 |
1,650,994 |
|||
|
Interest |
|
|
|
|||
|
Accrued interest |
105,603 |
98,309 |
203,912 |
|||
|
Modification of convertible loan note |
(35,476) |
(20,217) |
(55,693) |
|||
|
Total |
1,175,652 |
623,561 |
1,799,213 |
|||
8. Events after the balance sheet date
On 7 October 2025, the Company issued 1,666,666 new ordinary shares at a price of 30 pence per share, raising gross proceeds of £500,000.
On 8 October 2025, the Company issued 1,612,903 new ordinary shares at a price of 31 pence per share, raising gross proceeds of £500,000.
10. Prior period restatement
During the year ended 31 March 2025, the Group reassessed the classification of its convertible loan notes ("CLNs") under IAS 32 Financial Instruments: Presentation. The CLNs were previously accounted for as compound financial instruments, comprising a liability component and an equity component. On review of the contractual terms, it was determined that the conversion feature does not meet the "fixed-for-fixed" requirement in IAS 32. Consequently, no equity component should be recognised.
In reviewing the accounting for the Group's EMI share options and warrants scheme, management has refined the application of IFRS 2 Share-based Payments as no fair value charge was attributed to them at the time. Under IFRS 2, the fair value of equity-settled options and warrants is measured at the grant date and recognised as an expense over the vesting period, reflecting the services received from employees or consultants during that period.
Accordingly, the comparative figures have been restated to align with the requirements detailed above for the period ended 30 September 2024.
11. Approval of interim financial statements
The Condensed interim financial statements were approved by the Board of Directors on 8 December 2025.
12. Availability of this announcement
Copies of this announcement are available from Insig AI website at www.insg.ai.
**ENDS**
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 2 days ago City of London Investment Group
- 2 days ago Aberdeen Group plc
- 2 days ago NATWEST GROUP
- 2 days ago Ondo Insurtech
- 2 days ago Banco Santander S.A.